JNJ-7777120

JNJ-7777120 is a drug being developed by Johnson & Johnson Pharmaceutical Research & Development which acts as a potent and selective antagonist at the histamine H4 receptor. It has antiinflammatory effects, and has been demonstrated to be superior to traditional antihistamines in the treatment of pruritus (itching).